This year at SupplySide West (Mandalay Bay, Las Vegas, from 27th to 28th Sept 2017), we are excited to share with you our latest research on the DavosLife E3 Bio-Enhanced 20. Recent pharmacokinetic studies on DavosLife E3 Bio-Enhanced 20, a patent pending SEDS (self-emulsifying delivery system) formulated Tocotrienol-Rich Fraction has been clinically proven to increase absorption by 46% over market products. Higher plasma level of Tocotrienols, resulting in overall enhanced health benefits.
To learn more, visit our booth #P170. We look forward to meeting you.